Company Filing History:
Years Active: 2016-2018
Title: Innovations by Didier Rouy in Autologous Cell Therapy
Introduction
Didier Rouy is an accomplished inventor based in San Carlos, CA (US). He has made significant contributions to the field of autologous cell therapy, holding a total of 3 patents. His work focuses on methods for expanding mesenchymal cells derived from autologous bone marrow, which have promising applications in clinical settings.
Latest Patents
Rouy's latest patents include a method for preparing autologous cells and methods of use for therapy. This method involves expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium. It is designed for use in a clinical setting and includes a business method for performing such expansions as a service for patients in the future. Additionally, he has developed a diagnostic kit for autologous cell therapy, which helps determine whether a patient will respond to the treatment. This kit comprises a system for detecting gene and protein expression, utilizing at least two isolated DNA molecules that detect the expression of genes differentially expressed in the patient's tissue.
Career Highlights
Didier Rouy is currently associated with Biocardia, Inc., where he continues to innovate in the field of cell therapy. His work is pivotal in advancing therapeutic options for patients requiring autologous cell treatments.
Collaborations
Rouy collaborates with notable professionals in his field, including Benjamin Koziner and Peter A. Atlman. Their combined expertise contributes to the development of cutting-edge therapies and enhances the impact of their innovations.
Conclusion
Didier Rouy's contributions to autologous cell therapy represent a significant advancement in medical science. His innovative methods and collaborative efforts are paving the way for future therapies that can improve patient outcomes.